The pathobiological causes, the shared cellular and molecular pathways in catatonia and in
catatonic presentation in neuropsychiatric disorders are yet to be determined. The …

DISCUSSION The Hunter criteria suggest serotonin toxicity in the presence of a serotonergic
agent—paroxetine and quetiapine in this patient—and 1 of the 5 following clusters of …

Objective To develop consensus on diagnostic criteria for LUMBAR syndrome, the
association of segmental infantile hemangiomas that affect the Lower body with Urogenital …

Tardive dyskinesia (TD) research is at a crossroads because of renewed interest in this
syndrome following the successful development and regulatory approval of two novel …

Catatonia is common, and has an incidence in psychiatric inpatients from the USA, UK and
other western countries of 10%. Half of the patients with catatonia suffer from bipolar …

The start of the era of modern psychopharmacology can be dated from 1949, with the
introduction of lithium carbonate in Melbourne, Australia, as a selective and effective …

Olanzapine pamoate is an intramuscular depot injection for the treatment of schizophrenia.
Approximately 1.4% of patients develop a serious adverse event called post‐injection …

The involvement of certain recreational drugs, namely, hallucinogens, in the development of
hyperactive syndromes is well known, but not well studied. In this report, we expand on this …

Bewusstseinsstörungen sind nach Allgemeinanästhesien ein häufiges Phänomen. Neben
den klassischen Ursachen (z. B. Überhang von sedierenden Medikamenten) kann eine …

Neuroleptic malignant syndrome (NMS) is a rare, idiosyncratic, but life-threatening adverse
reaction associated with the use of antipsychotic drugs. It is characterized by a tetrad of …